Meyka Pro banner
Select Medical Holdings Corporation

Stay Updated with the Latest Select Medical Holdings Corporation SEM News in Real Time

Find SEM news now at Meyka AI. Stay informed with the latest Select Medical Holdings Corporation stocks updates, including price news, market analysis, and expert insights.

SEMNYSE
HealthcareMedical - Care Facilities
$16.51
$0.01(0.09%)
U.S. Market opens in 15h 38m
Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly
📅 in about 4 hours

Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly

Japan ends blanket 45-hour overtime guidance in September, allowing companies with special clauses to permit up to 100 hours monthly. Labor inspectors will focus on worker health protections instead.

Read more 12
Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21
📅 40 minutes ago

Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21

Moderna stock jumps 122% after announcing its personalized mRNA melanoma vaccine met Phase 3 trial goals. The vaccine reduced cancer recurrence and spread when combined with Merck’s Keytruda.

Read more 12
Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback
📅 4 hours ago

Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback

Robinhood stock closed at $95.77 on August 19, 2026, up 4.63% for the session. Strategy, Coinbase, and Circle all posted stronger gains the same day. The U.S. Treasury’s expanded bond buyback program eased yields and lifted risk appetite across crypto-linked equities. Bitcoin climbed above $68,000, extending gains into $71,600 territory by Thursday morning. Why Robinhood…

Read more 12
Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump
📅 6 hours ago

Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump

Hays stock edged up 0.52% on August 20, 2026, after the recruitment giant posted FY26 results. The company cut its total annual dividend by 65%, from 1.24 pence to 0.44 pence per share. Net fees fell as hiring activity stayed weak across Hays’ key markets. Investors focused on cost cuts and stabilizing margins rather than…

Read more 12
HMRC Sends 81,000 Crypto Tax Warning Letters as Enforcement Nearly Triples
📅 7 hours ago

HMRC Sends 81,000 Crypto Tax Warning Letters as Enforcement Nearly Triples

HMRC sent 81,000 crypto tax warning letters in 2025-26, up from 27,714 in 2023-24. Penalties for non-compliance can reach 100% of unpaid tax. New powers arrive May 2027.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 8 hours ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12
US Debt Rises $11.6 Trillion During Trump’s Two Terms, Outpacing Biden’s $8.4T
📅 10 hours ago

US Debt Rises $11.6 Trillion During Trump’s Two Terms, Outpacing Biden’s $8.4T

US debt has climbed $11.6 trillion across Donald Trump’s two terms combined, according to Treasury Department data released this week. That total spans both his 2017-2021 term and his current second term since January 2025. Biden’s single term added $8.4 trillion by comparison. Total US debt crossed $40 trillion for the first time on August…

Read more 12
Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
📅 12 hours ago

Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20

Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
📅 12 hours ago

Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update

Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.

Read more 12

SEM News FAQ